Contract manufacturers of approved products are required to register with the FDA and certain state agencies and are subject to periodic unannounced inspections to ensure compliance with regulatory requirements, including current Good Manufacturing Practices (cGMP). Changes to manufacturing processes may require prior FDA approval. Manufacturers must investigate and correct any deviations from cGMP and comply with reporting obligations. Noncompliance can result in legal or regulatory actions such as warning letters, suspension of manufacturing, product seizures, injunctions, civil penalties, or criminal prosecution. An annual program fee applies to marketed products. The FDA may withdraw product approval if compliance is not maintained or if post-market issues arise, which can lead to labeling revisions, post-market studies, distribution or marketing restrictions, product recalls, safety alerts, fines, holds on clinical trials, refusal to approve applications, injunctions, penalties, or exclusion from federal healthcare programs.
Veradermics Inc's Comment on Supply Chain
Contract manufacturers of approved products are required to register with the FDA and certain state agencies and are subject to periodic unannounced inspections to ensure compliance with regulatory requirements, including current Good Manufacturing Practices (cGMP). Changes to manufacturing processes may require prior FDA approval. Manufacturers must investigate and correct any deviations from cGMP and comply with reporting obligations. Noncompliance can result in legal or regulatory actions such as warning letters, suspension of manufacturing, product seizures, injunctions, civil penalties, or criminal prosecution. An annual program fee applies to marketed products. The FDA may withdraw product approval if compliance is not maintained or if post-market issues arise, which can lead to labeling revisions, post-market studies, distribution or marketing restrictions, product recalls, safety alerts, fines, holds on clinical trials, refusal to approve applications, injunctions, penalties, or exclusion from federal healthcare programs.
Sources:
Veradermics Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Veradermics Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
